Hong Tian Selected Research

Brain Injuries (Brain Injury)

11/2009	Adenosine A 2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice.
10/2009	Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Tian Research Topics

Disease

26	Infections 05/2024 - 12/2003
15	Neoplasms (Cancer) 05/2024 - 10/2013
8	Body Weight (Weight, Body) 01/2022 - 12/2003
8	Retinal Neovascularization 01/2022 - 01/2017
7	Male Infertility (Male Sterility) 01/2019 - 11/2006
5	Leukemia 05/2024 - 06/2005
5	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2023 - 01/2017
5	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 01/2017
5	Inflammation (Inflammations) 01/2020 - 10/2012
5	Pain (Aches) 11/2019 - 03/2017
4	African Swine Fever 08/2023 - 02/2022
4	Pathologic Neovascularization 07/2023 - 01/2018
4	Virus Diseases (Viral Diseases) 01/2022 - 01/2018
4	Choroidal Neovascularization 01/2022 - 11/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 09/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2014 - 08/2002
4	Varicocele 10/2012 - 11/2006
4	Infertility (Sterility) 11/2009 - 11/2006
3	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2006
3	Meige Syndrome 01/2023 - 01/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2020
3	Blindness (Hysterical Blindness) 01/2022 - 05/2021
3	Hyperalgesia 10/2018 - 09/2017
3	Neuralgia (Stump Neuralgia) 10/2018 - 09/2017
3	Hypoxia (Hypoxemia) 02/2016 - 02/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2013 - 03/2007
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2008 - 08/2002
2	COVID-19 12/2024 - 03/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 09/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2014
2	Obesity 01/2022 - 01/2016
2	Residual Neoplasm 01/2022 - 11/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2020
2	Multiple Myeloma 01/2022 - 10/2021
2	Vascular Diseases (Vascular Disease) 05/2021 - 11/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 11/2020
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 04/2012
2	Cerebral Infarction 01/2016 - 11/2009
2	Stroke (Strokes) 01/2016 - 01/2014
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 11/2009
2	Hematologic Neoplasms (Hematological Malignancy) 10/2013 - 08/2002

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2006
12	VaccinesIBA 05/2024 - 06/2010
9	secretogranin IIIIBA 07/2023 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 02/2011
8	Messenger RNA (mRNA)IBA 01/2023 - 12/2003
8	Retinaldehyde (Retinal)IBA 01/2022 - 01/2017
7	Peptides (Polypeptides)IBA 05/2024 - 10/2013
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2023 - 06/2009
6	AntibodiesIBA 07/2023 - 06/2010
5	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2017
5	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2015
5	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2022 - 01/2018
5	Monoclonal AntibodiesIBA 01/2022 - 01/2019
5	Oxygen (Dioxygen)IBA 01/2019 - 02/2016
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2013
4	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2014
4	Streptozocin (Streptozotocin)FDA Link 12/2020 - 03/2007
4	CytokinesIBA 01/2020 - 01/2013
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 08/2002
4	AntigensIBA 10/2013 - 03/2008
3	ChemokinesIBA 01/2024 - 01/2020
3	Polysaccharides (Glycans)IBA 01/2024 - 03/2007
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 08/2013
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 09/2010
3	Neutralizing AntibodiesIBA 08/2019 - 11/2017
3	EpitopesIBA 01/2019 - 01/2014
3	Ubiquitin-Specific ProteasesIBA 01/2019 - 11/2007
3	RivaroxabanIBA 01/2018 - 02/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2012
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024 - 01/2020
2	InterferonsIBA 03/2024 - 10/2022
2	EnzymesIBA 01/2024 - 10/2012
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2021
2	SodiumIBA 10/2022 - 01/2015
2	afliberceptIBA 01/2022 - 01/2022
2	Interferon Type IIBA 01/2022 - 01/2019
2	Proteasome InhibitorsIBA 01/2022 - 10/2021
2	LipidsIBA 12/2020 - 01/2016
2	LigandsIBA 01/2020 - 01/2017
2	Hormones (Hormone)IBA 01/2019 - 01/2016
2	CalciumIBA 01/2018 - 11/2009
2	CanagliflozinIBA 01/2016 - 01/2015
2	Tyrosine (L-Tyrosine)FDA Link 02/2014 - 06/2009
2	CollagenIBA 08/2013 - 12/2003

Therapy/Procedure

16	Therapeutics 01/2022 - 06/2008
5	Immunotherapy 03/2024 - 10/2013
5	Drug Therapy (Chemotherapy) 01/2023 - 08/2002
4	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2014
3	Deep Brain Stimulation 01/2023 - 01/2019
3	Transplantation 01/2022 - 12/2003
2	Oral Administration 01/2022 - 01/2020
2	Intravitreal Injections 01/2022 - 11/2017
2	Lasers (Laser) 01/2022 - 11/2017
2	Induction Chemotherapy 11/2021 - 01/2016
2	Ligation 01/2020 - 01/2016
2	Spinal Injections 10/2018 - 09/2017